High FAK combined with low JWA expression: clinical prognostic and predictive role for adjuvant fluorouracil-leucovorin-oxaliplatin treatment in resectable gastric cancer patients. [electronic resource]
Producer: 20140418Description: 1034-44 p. digitalISSN:- 1435-5922
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- metabolism
- Chemotherapy, Adjuvant
- Female
- Fluorouracil -- administration & dosage
- Focal Adhesion Kinase 2 -- metabolism
- Gastrectomy
- Heat-Shock Proteins -- metabolism
- Humans
- Intracellular Signaling Peptides and Proteins -- metabolism
- Leucovorin -- administration & dosage
- Male
- Membrane Transport Proteins
- Middle Aged
- Neoplasm Staging
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Prognosis
- Retrospective Studies
- Stomach Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.